J.P. Morgan Healthcare Conference 2016: Medtronic to return $5 billion of freed cash to shareholders Jan. 13, 2016 By Amanda Pedersen SAN FRANCISCO — As Medtronic plc (Dublin) approaches the anniversary of its blockbuster Covidien deal, which closed a year ago this month, the company is making strides to prove the $42.9 billion acquisition is paying off.Read More
J.P. Morgan Healthcare Conference 2016: Illumina finds its 'holy grail' in early cancer detection with new spinout Jan. 12, 2016 By Omar Ford
Inside the Beltway: Risk of nephropathy seen as nearly equal for contrast agents Jan. 12, 2016 By Mark McCarty
Looking beyond Internal R&D: Johnson & Johnson highlights focus on external innovation Jan. 12, 2016 By Cornelia Zou
RSS